Biochemistry, Genetics and Molecular Biology
Allele
13%
B Cell
26%
BCL6
5%
BCR (Gene)
8%
Carcinogenesis
7%
Cell Oncogene
11%
Centromere
14%
Chromosomal Aberration
5%
Chromosomal Rearrangement
6%
Chromosomal Translocation
7%
Chromosome 7
5%
Chromosome 9
7%
Chromosome Abnormality
7%
Chromosome Band
9%
Chromosome Breakage
13%
Chromosome Change
15%
Chromosome NOR
5%
Clonal Evolution
8%
Cytogenetics
100%
Epidermal Growth Factor Receptor
6%
Fluorescence in Situ Hybridization
10%
Gene Mutation
11%
Genetics
22%
Genomics
8%
Immunophenotyping
7%
Inbred Strain
6%
Interphase
5%
Intravenous Immunoglobulin
9%
Karyotype
34%
Metaphase
9%
Microarrays
7%
Molecular Genetics
14%
Monosomy
7%
Morphology
10%
Mosaicism
8%
Mouse
6%
Myeloid
35%
Overall Survival
11%
P53
13%
Pachytene
10%
Pennisetum
20%
Point Mutation
6%
Promoter Region
5%
Reciprocal Chromosome Translocation
9%
RUNX1
6%
Trisomy
12%
Trisomy 8
5%
Tumor Progression
6%
Tumor Suppressor Gene
5%
Wild Type
7%
Medicine and Dentistry
Acute Leukemia
34%
Acute Myeloid Leukemia
30%
Angiosarcoma
8%
B-Cell Chronic Lymphocytic Leukemia
9%
B-Cell Lymphoma
8%
Biological Marker
9%
Burkitt's Lymphoma
6%
Carcinoma
5%
Chromosome Translocation
6%
Chronic Myelogenous Leukemia
8%
Clear Cell Renal Cell Carcinoma
5%
Clinical Significance
9%
Cumulative Incidence
8%
De Novo Acute Myeloid Leukemia
10%
Diagnosis
10%
Diffuse Large B-Cell Lymphoma
7%
Disease
7%
Disease Free Survival
7%
Endometrial Cancer
8%
Fibroblast Growth Factor Receptor 1
8%
Flow Cytometry
13%
Fluorescence in Situ Hybridization
25%
Follicular Lymphoma
9%
Germinoma
5%
Hypereosinophilia
6%
Immunoglobulin
5%
Immunohistochemistry
9%
Immunophenotyping
13%
Karyotype
23%
Large-Cell Lymphoma
6%
Leukemia
20%
Leukemia Cell
6%
Lymphoid Leukemia
22%
Lymphoma Cell
7%
Malignant Neoplasm
26%
Minimal Residual Disease
7%
Molar Pregnancy
5%
Morphology
12%
Multiple Myeloma
5%
Myelodysplastic Syndrome
6%
Neoplasm
37%
Next Generation Sequencing
6%
Non-Hodgkin Lymphoma
5%
Overall Survival
11%
P16
8%
Pediatrics Patient
8%
Philadelphia 1 Chromosome
8%
Salivary Gland
7%
T Cell
10%
Tumor Cell
6%
Keyphrases
Acute Myeloid Leukemia
13%
Additional Cytogenetic Abnormalities
5%
B Cells
6%
B-lymphoblastic Leukemia
8%
Bone Marrow Involvement
7%
Breakage
8%
Chromosomal Aberrations
5%
Chromosome Abnormalities
5%
Chromosome Breakage
5%
Chromosome Rearrangement
5%
Chronic Myeloid Leukemia
12%
Co-orientation
6%
Cytogenetic Abnormalities
5%
De Novo Acute Myeloid Leukemia
5%
Endometrial Cancer
8%
Immunophenotypic Profile
6%
Immunophenotyping
16%
Inv(16)
8%
Lymphoma
13%
Metaphase I
8%
Mixed-phenotype Acute Leukemia
17%
Myelodysplastic Syndrome
8%
Non-Hodgkin Lymphoma
8%
Overall Survival
5%
Relapse-free Survival
7%
Retroperitoneal Lymphadenopathy
5%
T Cells
5%
Tumorigenesis
5%
Variant Translocation
5%
